nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—ABCB1—Ezetimibe—atherosclerosis	0.0556	0.267	CbGbCtD
Gemcitabine—ABCB1—Simvastatin—atherosclerosis	0.0517	0.248	CbGbCtD
Gemcitabine—ABCB1—Pravastatin—atherosclerosis	0.0506	0.243	CbGbCtD
Gemcitabine—ABCB1—Lovastatin—atherosclerosis	0.0506	0.243	CbGbCtD
Gemcitabine—SLC28A1—liver—atherosclerosis	0.00604	0.0491	CbGeAlD
Gemcitabine—CMPK1—connective tissue—atherosclerosis	0.00597	0.0484	CbGeAlD
Gemcitabine—POLD1—adipose tissue—atherosclerosis	0.00574	0.0466	CbGeAlD
Gemcitabine—SLC29A2—cardiovascular system—atherosclerosis	0.00546	0.0443	CbGeAlD
Gemcitabine—SLC28A3—adipose tissue—atherosclerosis	0.00526	0.0427	CbGeAlD
Gemcitabine—CMPK1—cardiovascular system—atherosclerosis	0.00519	0.0422	CbGeAlD
Gemcitabine—CDA—adipose tissue—atherosclerosis	0.00515	0.0418	CbGeAlD
Gemcitabine—SLC29A2—adipose tissue—atherosclerosis	0.00481	0.0391	CbGeAlD
Gemcitabine—CMPK1—adipose tissue—atherosclerosis	0.00458	0.0372	CbGeAlD
Gemcitabine—POLE—adipose tissue—atherosclerosis	0.00429	0.0348	CbGeAlD
Gemcitabine—POLD1—liver—atherosclerosis	0.00402	0.0327	CbGeAlD
Gemcitabine—RRM2—cardiovascular system—atherosclerosis	0.00401	0.0325	CbGeAlD
Gemcitabine—POLA1—adipose tissue—atherosclerosis	0.0037	0.03	CbGeAlD
Gemcitabine—CDA—liver—atherosclerosis	0.00361	0.0293	CbGeAlD
Gemcitabine—RRM2—adipose tissue—atherosclerosis	0.00353	0.0287	CbGeAlD
Gemcitabine—TYMS—connective tissue—atherosclerosis	0.00347	0.0282	CbGeAlD
Gemcitabine—SLC29A2—liver—atherosclerosis	0.00338	0.0274	CbGeAlD
Gemcitabine—RRM1—cardiovascular system—atherosclerosis	0.00333	0.027	CbGeAlD
Gemcitabine—CMPK1—liver—atherosclerosis	0.00321	0.0261	CbGeAlD
Gemcitabine—SLC29A1—connective tissue—atherosclerosis	0.00311	0.0253	CbGeAlD
Gemcitabine—POLE—liver—atherosclerosis	0.00301	0.0244	CbGeAlD
Gemcitabine—RRM1—adipose tissue—atherosclerosis	0.00293	0.0238	CbGeAlD
Gemcitabine—DCK—Simvastatin—Lovastatin—atherosclerosis	0.0029	0.203	CbGdCrCtD
Gemcitabine—DCK—Simvastatin—Pravastatin—atherosclerosis	0.0029	0.203	CbGdCrCtD
Gemcitabine—SLC29A1—cardiovascular system—atherosclerosis	0.00271	0.022	CbGeAlD
Gemcitabine—TYMS—adipose tissue—atherosclerosis	0.00266	0.0216	CbGeAlD
Gemcitabine—POLA1—liver—atherosclerosis	0.00259	0.0211	CbGeAlD
Gemcitabine—RRM2—liver—atherosclerosis	0.00248	0.0201	CbGeAlD
Gemcitabine—Hepatic failure—Simvastatin—atherosclerosis	0.00245	0.00532	CcSEcCtD
Gemcitabine—Influenza—Rosuvastatin—atherosclerosis	0.0024	0.00522	CcSEcCtD
Gemcitabine—SLC29A1—adipose tissue—atherosclerosis	0.00239	0.0194	CbGeAlD
Gemcitabine—Hepatic function abnormal—Niacin—atherosclerosis	0.00231	0.00503	CcSEcCtD
Gemcitabine—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.00229	0.00497	CcSEcCtD
Gemcitabine—TYMS—Fluvastatin—Rosuvastatin—atherosclerosis	0.00229	0.16	CbGdCrCtD
Gemcitabine—DCK—adipose tissue—atherosclerosis	0.00228	0.0185	CbGeAlD
Gemcitabine—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00228	0.00495	CcSEcCtD
Gemcitabine—Deafness—Pravastatin—atherosclerosis	0.00222	0.00483	CcSEcCtD
Gemcitabine—Hepatic failure—Pravastatin—atherosclerosis	0.00221	0.00481	CcSEcCtD
Gemcitabine—TYMS—Simvastatin—Lovastatin—atherosclerosis	0.00219	0.153	CbGdCrCtD
Gemcitabine—TYMS—Simvastatin—Pravastatin—atherosclerosis	0.00219	0.153	CbGdCrCtD
Gemcitabine—ABCC10—adipose tissue—atherosclerosis	0.00217	0.0176	CbGeAlD
Gemcitabine—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00213	0.00463	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00212	0.0046	CcSEcCtD
Gemcitabine—Dermatitis bullous—Niacin—atherosclerosis	0.00212	0.0046	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.0021	0.00456	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00208	0.00452	CcSEcCtD
Gemcitabine—RRM1—liver—atherosclerosis	0.00206	0.0167	CbGeAlD
Gemcitabine—Haematuria—Rosuvastatin—atherosclerosis	0.00204	0.00443	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00204	0.00442	CcSEcCtD
Gemcitabine—Influenza—Lovastatin—atherosclerosis	0.00203	0.00442	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00202	0.0044	CcSEcCtD
Gemcitabine—Influenza—Ezetimibe—atherosclerosis	0.002	0.00433	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00198	0.00431	CcSEcCtD
Gemcitabine—Face oedema—Niacin—atherosclerosis	0.00195	0.00424	CcSEcCtD
Gemcitabine—Rhinitis—Rosuvastatin—atherosclerosis	0.00193	0.00418	CcSEcCtD
Gemcitabine—Pharyngitis—Rosuvastatin—atherosclerosis	0.00191	0.00414	CcSEcCtD
Gemcitabine—Liver function test abnormal—Niacin—atherosclerosis	0.00187	0.00405	CcSEcCtD
Gemcitabine—TYMS—liver—atherosclerosis	0.00187	0.0152	CbGeAlD
Gemcitabine—TYMS—Pitavastatin—Rosuvastatin—atherosclerosis	0.00186	0.13	CbGdCrCtD
Gemcitabine—Liver function test abnormal—Pravastatin—atherosclerosis	0.00184	0.00399	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.0018	0.00391	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00179	0.00389	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00178	0.00386	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00176	0.00381	CcSEcCtD
Gemcitabine—Influenza—Niacin—atherosclerosis	0.00175	0.0038	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00174	0.00379	CcSEcCtD
Gemcitabine—Influenza—Pravastatin—atherosclerosis	0.00172	0.00374	CcSEcCtD
Gemcitabine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00172	0.00373	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00168	0.00366	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00168	0.00365	CcSEcCtD
Gemcitabine—SLC29A1—liver—atherosclerosis	0.00167	0.0136	CbGeAlD
Gemcitabine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00166	0.00361	CcSEcCtD
Gemcitabine—DCK—liver—atherosclerosis	0.0016	0.013	CbGeAlD
Gemcitabine—ABCB1—blood vessel—atherosclerosis	0.00159	0.0129	CbGeAlD
Gemcitabine—Pharyngitis—Ezetimibe—atherosclerosis	0.00159	0.00344	CcSEcCtD
Gemcitabine—Oedema peripheral—Ezetimibe—atherosclerosis	0.00157	0.00342	CcSEcCtD
Gemcitabine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00157	0.00341	CcSEcCtD
Gemcitabine—Erythema multiforme—Lovastatin—atherosclerosis	0.00154	0.00334	CcSEcCtD
Gemcitabine—ABCC10—liver—atherosclerosis	0.00152	0.0124	CbGeAlD
Gemcitabine—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00152	0.0033	CcSEcCtD
Gemcitabine—Stomatitis—Niacin—atherosclerosis	0.00152	0.0033	CcSEcCtD
Gemcitabine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00151	0.00329	CcSEcCtD
Gemcitabine—Erythema multiforme—Ezetimibe—atherosclerosis	0.00151	0.00328	CcSEcCtD
Gemcitabine—Myocardial infarction—Pravastatin—atherosclerosis	0.0015	0.00327	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.0015	0.00327	CcSEcCtD
Gemcitabine—Sweating—Niacin—atherosclerosis	0.00149	0.00324	CcSEcCtD
Gemcitabine—Chills—Lovastatin—atherosclerosis	0.00146	0.00317	CcSEcCtD
Gemcitabine—Cough—Rosuvastatin—atherosclerosis	0.00146	0.00317	CcSEcCtD
Gemcitabine—Angiopathy—Ezetimibe—atherosclerosis	0.00145	0.00315	CcSEcCtD
Gemcitabine—Immune system disorder—Ezetimibe—atherosclerosis	0.00144	0.00313	CcSEcCtD
Gemcitabine—Erythema multiforme—Simvastatin—atherosclerosis	0.00144	0.00313	CcSEcCtD
Gemcitabine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00144	0.00313	CcSEcCtD
Gemcitabine—Alopecia—Lovastatin—atherosclerosis	0.00144	0.00313	CcSEcCtD
Gemcitabine—Arthralgia—Rosuvastatin—atherosclerosis	0.00142	0.00309	CcSEcCtD
Gemcitabine—Myalgia—Rosuvastatin—atherosclerosis	0.00142	0.00309	CcSEcCtD
Gemcitabine—Alopecia—Ezetimibe—atherosclerosis	0.00141	0.00307	CcSEcCtD
Gemcitabine—Haemoglobin—Niacin—atherosclerosis	0.00141	0.00305	CcSEcCtD
Gemcitabine—Rhinitis—Niacin—atherosclerosis	0.0014	0.00305	CcSEcCtD
Gemcitabine—Haemorrhage—Niacin—atherosclerosis	0.0014	0.00304	CcSEcCtD
Gemcitabine—Erythema—Ezetimibe—atherosclerosis	0.00139	0.00302	CcSEcCtD
Gemcitabine—Rhinitis—Pravastatin—atherosclerosis	0.00138	0.003	CcSEcCtD
Gemcitabine—Oedema peripheral—Niacin—atherosclerosis	0.00138	0.00299	CcSEcCtD
Gemcitabine—Back pain—Lovastatin—atherosclerosis	0.00137	0.00298	CcSEcCtD
Gemcitabine—Pharyngitis—Pravastatin—atherosclerosis	0.00137	0.00297	CcSEcCtD
Gemcitabine—Chills—Simvastatin—atherosclerosis	0.00137	0.00297	CcSEcCtD
Gemcitabine—Infection—Rosuvastatin—atherosclerosis	0.00136	0.00295	CcSEcCtD
Gemcitabine—Alopecia—Simvastatin—atherosclerosis	0.00135	0.00292	CcSEcCtD
Gemcitabine—Back pain—Ezetimibe—atherosclerosis	0.00134	0.00292	CcSEcCtD
Gemcitabine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00134	0.00291	CcSEcCtD
Gemcitabine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00134	0.0029	CcSEcCtD
Gemcitabine—Erythema—Simvastatin—atherosclerosis	0.00133	0.00288	CcSEcCtD
Gemcitabine—Ill-defined disorder—Lovastatin—atherosclerosis	0.00132	0.00286	CcSEcCtD
Gemcitabine—Erythema multiforme—Pravastatin—atherosclerosis	0.0013	0.00283	CcSEcCtD
Gemcitabine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00129	0.0028	CcSEcCtD
Gemcitabine—Anaemia—Ezetimibe—atherosclerosis	0.00128	0.00279	CcSEcCtD
Gemcitabine—Malaise—Lovastatin—atherosclerosis	0.00128	0.00278	CcSEcCtD
Gemcitabine—Cardiac disorder—Pravastatin—atherosclerosis	0.00128	0.00278	CcSEcCtD
Gemcitabine—Angiopathy—Niacin—atherosclerosis	0.00127	0.00276	CcSEcCtD
Gemcitabine—Leukopenia—Lovastatin—atherosclerosis	0.00127	0.00276	CcSEcCtD
Gemcitabine—Chills—Niacin—atherosclerosis	0.00125	0.00273	CcSEcCtD
Gemcitabine—Malaise—Ezetimibe—atherosclerosis	0.00125	0.00272	CcSEcCtD
Gemcitabine—Arrhythmia—Niacin—atherosclerosis	0.00125	0.00271	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00124	0.0027	CcSEcCtD
Gemcitabine—Alopecia—Niacin—atherosclerosis	0.00124	0.00268	CcSEcCtD
Gemcitabine—Chills—Pravastatin—atherosclerosis	0.00124	0.00268	CcSEcCtD
Gemcitabine—Insomnia—Rosuvastatin—atherosclerosis	0.00123	0.00268	CcSEcCtD
Gemcitabine—Ill-defined disorder—Simvastatin—atherosclerosis	0.00123	0.00267	CcSEcCtD
Gemcitabine—Arrhythmia—Pravastatin—atherosclerosis	0.00123	0.00267	CcSEcCtD
Gemcitabine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00123	0.00266	CcSEcCtD
Gemcitabine—Anaemia—Simvastatin—atherosclerosis	0.00123	0.00266	CcSEcCtD
Gemcitabine—Erythema—Niacin—atherosclerosis	0.00122	0.00264	CcSEcCtD
Gemcitabine—Alopecia—Pravastatin—atherosclerosis	0.00122	0.00264	CcSEcCtD
Gemcitabine—Cough—Ezetimibe—atherosclerosis	0.00121	0.00264	CcSEcCtD
Gemcitabine—Chest pain—Lovastatin—atherosclerosis	0.00121	0.00262	CcSEcCtD
Gemcitabine—Myalgia—Lovastatin—atherosclerosis	0.00121	0.00262	CcSEcCtD
Gemcitabine—Arthralgia—Lovastatin—atherosclerosis	0.00121	0.00262	CcSEcCtD
Gemcitabine—Hypertension—Ezetimibe—atherosclerosis	0.0012	0.00261	CcSEcCtD
Gemcitabine—Malaise—Simvastatin—atherosclerosis	0.0012	0.0026	CcSEcCtD
Gemcitabine—Discomfort—Lovastatin—atherosclerosis	0.00119	0.00259	CcSEcCtD
Gemcitabine—Leukopenia—Simvastatin—atherosclerosis	0.00119	0.00258	CcSEcCtD
Gemcitabine—Chest pain—Ezetimibe—atherosclerosis	0.00118	0.00257	CcSEcCtD
Gemcitabine—Myalgia—Ezetimibe—atherosclerosis	0.00118	0.00257	CcSEcCtD
Gemcitabine—Arthralgia—Ezetimibe—atherosclerosis	0.00118	0.00257	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00118	0.00255	CcSEcCtD
Gemcitabine—Discomfort—Ezetimibe—atherosclerosis	0.00117	0.00254	CcSEcCtD
Gemcitabine—Constipation—Rosuvastatin—atherosclerosis	0.00117	0.00254	CcSEcCtD
Gemcitabine—Pain—Rosuvastatin—atherosclerosis	0.00117	0.00254	CcSEcCtD
Gemcitabine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00116	0.00251	CcSEcCtD
Gemcitabine—Infection—Lovastatin—atherosclerosis	0.00115	0.0025	CcSEcCtD
Gemcitabine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00113	0.00247	CcSEcCtD
Gemcitabine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00113	0.00246	CcSEcCtD
Gemcitabine—Myalgia—Simvastatin—atherosclerosis	0.00113	0.00245	CcSEcCtD
Gemcitabine—Arthralgia—Simvastatin—atherosclerosis	0.00113	0.00245	CcSEcCtD
Gemcitabine—Chest pain—Simvastatin—atherosclerosis	0.00113	0.00245	CcSEcCtD
Gemcitabine—Infection—Ezetimibe—atherosclerosis	0.00113	0.00245	CcSEcCtD
Gemcitabine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00112	0.00244	CcSEcCtD
Gemcitabine—Discomfort—Simvastatin—atherosclerosis	0.00112	0.00242	CcSEcCtD
Gemcitabine—Nervous system disorder—Ezetimibe—atherosclerosis	0.00111	0.00242	CcSEcCtD
Gemcitabine—Ill-defined disorder—Pravastatin—atherosclerosis	0.00111	0.00242	CcSEcCtD
Gemcitabine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00111	0.00241	CcSEcCtD
Gemcitabine—Anaemia—Pravastatin—atherosclerosis	0.00111	0.00241	CcSEcCtD
Gemcitabine—Anorexia—Lovastatin—atherosclerosis	0.0011	0.0024	CcSEcCtD
Gemcitabine—Skin disorder—Ezetimibe—atherosclerosis	0.0011	0.00239	CcSEcCtD
Gemcitabine—Leukopenia—Niacin—atherosclerosis	0.00109	0.00237	CcSEcCtD
Gemcitabine—Oedema—Simvastatin—atherosclerosis	0.00108	0.00235	CcSEcCtD
Gemcitabine—Anaphylactic shock—Simvastatin—atherosclerosis	0.00108	0.00235	CcSEcCtD
Gemcitabine—Malaise—Pravastatin—atherosclerosis	0.00108	0.00235	CcSEcCtD
Gemcitabine—Infection—Simvastatin—atherosclerosis	0.00107	0.00234	CcSEcCtD
Gemcitabine—Leukopenia—Pravastatin—atherosclerosis	0.00107	0.00233	CcSEcCtD
Gemcitabine—Cough—Niacin—atherosclerosis	0.00106	0.00231	CcSEcCtD
Gemcitabine—Thrombocytopenia—Simvastatin—atherosclerosis	0.00106	0.0023	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00105	0.00229	CcSEcCtD
Gemcitabine—Insomnia—Lovastatin—atherosclerosis	0.00105	0.00227	CcSEcCtD
Gemcitabine—Cough—Pravastatin—atherosclerosis	0.00105	0.00227	CcSEcCtD
Gemcitabine—Paraesthesia—Lovastatin—atherosclerosis	0.00104	0.00226	CcSEcCtD
Gemcitabine—Myalgia—Niacin—atherosclerosis	0.00104	0.00225	CcSEcCtD
Gemcitabine—Arthralgia—Niacin—atherosclerosis	0.00104	0.00225	CcSEcCtD
Gemcitabine—Hypertension—Pravastatin—atherosclerosis	0.00103	0.00225	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00103	0.00225	CcSEcCtD
Gemcitabine—Anorexia—Simvastatin—atherosclerosis	0.00103	0.00224	CcSEcCtD
Gemcitabine—Dyspnoea—Lovastatin—atherosclerosis	0.00103	0.00224	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00103	0.00224	CcSEcCtD
Gemcitabine—Insomnia—Ezetimibe—atherosclerosis	0.00103	0.00223	CcSEcCtD
Gemcitabine—Arthralgia—Pravastatin—atherosclerosis	0.00102	0.00222	CcSEcCtD
Gemcitabine—Myalgia—Pravastatin—atherosclerosis	0.00102	0.00222	CcSEcCtD
Gemcitabine—Chest pain—Pravastatin—atherosclerosis	0.00102	0.00222	CcSEcCtD
Gemcitabine—Paraesthesia—Ezetimibe—atherosclerosis	0.00102	0.00221	CcSEcCtD
Gemcitabine—Dyspnoea—Ezetimibe—atherosclerosis	0.00101	0.0022	CcSEcCtD
Gemcitabine—Discomfort—Pravastatin—atherosclerosis	0.00101	0.00219	CcSEcCtD
Gemcitabine—Decreased appetite—Lovastatin—atherosclerosis	0.00101	0.00218	CcSEcCtD
Gemcitabine—Fatigue—Lovastatin—atherosclerosis	0.000997	0.00217	CcSEcCtD
Gemcitabine—Anaphylactic shock—Niacin—atherosclerosis	0.000994	0.00216	CcSEcCtD
Gemcitabine—Oedema—Niacin—atherosclerosis	0.000994	0.00216	CcSEcCtD
Gemcitabine—Constipation—Lovastatin—atherosclerosis	0.000989	0.00215	CcSEcCtD
Gemcitabine—Pain—Lovastatin—atherosclerosis	0.000989	0.00215	CcSEcCtD
Gemcitabine—Decreased appetite—Ezetimibe—atherosclerosis	0.000986	0.00214	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000986	0.00214	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00098	0.00213	CcSEcCtD
Gemcitabine—Asthenia—Rosuvastatin—atherosclerosis	0.000979	0.00213	CcSEcCtD
Gemcitabine—Insomnia—Simvastatin—atherosclerosis	0.000979	0.00213	CcSEcCtD
Gemcitabine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000978	0.00213	CcSEcCtD
Gemcitabine—Oedema—Pravastatin—atherosclerosis	0.000978	0.00213	CcSEcCtD
Gemcitabine—Fatigue—Ezetimibe—atherosclerosis	0.000978	0.00213	CcSEcCtD
Gemcitabine—Infection—Pravastatin—atherosclerosis	0.000972	0.00211	CcSEcCtD
Gemcitabine—Paraesthesia—Simvastatin—atherosclerosis	0.000972	0.00211	CcSEcCtD
Gemcitabine—Constipation—Ezetimibe—atherosclerosis	0.00097	0.00211	CcSEcCtD
Gemcitabine—Pain—Ezetimibe—atherosclerosis	0.00097	0.00211	CcSEcCtD
Gemcitabine—Pruritus—Rosuvastatin—atherosclerosis	0.000966	0.0021	CcSEcCtD
Gemcitabine—Skin disorder—Niacin—atherosclerosis	0.000965	0.0021	CcSEcCtD
Gemcitabine—Dyspnoea—Simvastatin—atherosclerosis	0.000965	0.0021	CcSEcCtD
Gemcitabine—Hyperhidrosis—Niacin—atherosclerosis	0.00096	0.00209	CcSEcCtD
Gemcitabine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000958	0.00208	CcSEcCtD
Gemcitabine—Feeling abnormal—Lovastatin—atherosclerosis	0.000953	0.00207	CcSEcCtD
Gemcitabine—Anorexia—Niacin—atherosclerosis	0.000947	0.00206	CcSEcCtD
Gemcitabine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000946	0.00205	CcSEcCtD
Gemcitabine—Decreased appetite—Simvastatin—atherosclerosis	0.000941	0.00204	CcSEcCtD
Gemcitabine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000935	0.00203	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000934	0.00203	CcSEcCtD
Gemcitabine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000934	0.00203	CcSEcCtD
Gemcitabine—Fatigue—Simvastatin—atherosclerosis	0.000933	0.00203	CcSEcCtD
Gemcitabine—Anorexia—Pravastatin—atherosclerosis	0.000932	0.00203	CcSEcCtD
Gemcitabine—Hypotension—Niacin—atherosclerosis	0.000928	0.00202	CcSEcCtD
Gemcitabine—Pain—Simvastatin—atherosclerosis	0.000925	0.00201	CcSEcCtD
Gemcitabine—Constipation—Simvastatin—atherosclerosis	0.000925	0.00201	CcSEcCtD
Gemcitabine—Body temperature increased—Lovastatin—atherosclerosis	0.000914	0.00199	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000905	0.00197	CcSEcCtD
Gemcitabine—Insomnia—Niacin—atherosclerosis	0.000899	0.00195	CcSEcCtD
Gemcitabine—Body temperature increased—Ezetimibe—atherosclerosis	0.000897	0.00195	CcSEcCtD
Gemcitabine—Paraesthesia—Niacin—atherosclerosis	0.000892	0.00194	CcSEcCtD
Gemcitabine—Feeling abnormal—Simvastatin—atherosclerosis	0.000892	0.00194	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000891	0.00194	CcSEcCtD
Gemcitabine—Dyspnoea—Niacin—atherosclerosis	0.000886	0.00192	CcSEcCtD
Gemcitabine—Insomnia—Pravastatin—atherosclerosis	0.000885	0.00192	CcSEcCtD
Gemcitabine—Somnolence—Niacin—atherosclerosis	0.000883	0.00192	CcSEcCtD
Gemcitabine—Paraesthesia—Pravastatin—atherosclerosis	0.000878	0.00191	CcSEcCtD
Gemcitabine—Dyspnoea—Pravastatin—atherosclerosis	0.000872	0.00189	CcSEcCtD
Gemcitabine—Decreased appetite—Niacin—atherosclerosis	0.000864	0.00188	CcSEcCtD
Gemcitabine—Rash—Rosuvastatin—atherosclerosis	0.000861	0.00187	CcSEcCtD
Gemcitabine—Dermatitis—Rosuvastatin—atherosclerosis	0.00086	0.00187	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000858	0.00186	CcSEcCtD
Gemcitabine—Body temperature increased—Simvastatin—atherosclerosis	0.000855	0.00186	CcSEcCtD
Gemcitabine—Headache—Rosuvastatin—atherosclerosis	0.000855	0.00186	CcSEcCtD
Gemcitabine—Decreased appetite—Pravastatin—atherosclerosis	0.00085	0.00185	CcSEcCtD
Gemcitabine—Pain—Niacin—atherosclerosis	0.00085	0.00185	CcSEcCtD
Gemcitabine—Fatigue—Pravastatin—atherosclerosis	0.000843	0.00183	CcSEcCtD
Gemcitabine—Constipation—Pravastatin—atherosclerosis	0.000837	0.00182	CcSEcCtD
Gemcitabine—Pain—Pravastatin—atherosclerosis	0.000837	0.00182	CcSEcCtD
Gemcitabine—Asthenia—Lovastatin—atherosclerosis	0.00083	0.0018	CcSEcCtD
Gemcitabine—Pruritus—Lovastatin—atherosclerosis	0.000818	0.00178	CcSEcCtD
Gemcitabine—Asthenia—Ezetimibe—atherosclerosis	0.000814	0.00177	CcSEcCtD
Gemcitabine—Nausea—Rosuvastatin—atherosclerosis	0.000811	0.00176	CcSEcCtD
Gemcitabine—Feeling abnormal—Pravastatin—atherosclerosis	0.000806	0.00175	CcSEcCtD
Gemcitabine—Pruritus—Ezetimibe—atherosclerosis	0.000803	0.00174	CcSEcCtD
Gemcitabine—Diarrhoea—Lovastatin—atherosclerosis	0.000792	0.00172	CcSEcCtD
Gemcitabine—Body temperature increased—Niacin—atherosclerosis	0.000785	0.00171	CcSEcCtD
Gemcitabine—Asthenia—Simvastatin—atherosclerosis	0.000776	0.00169	CcSEcCtD
Gemcitabine—Diarrhoea—Ezetimibe—atherosclerosis	0.000776	0.00169	CcSEcCtD
Gemcitabine—Body temperature increased—Pravastatin—atherosclerosis	0.000773	0.00168	CcSEcCtD
Gemcitabine—Pruritus—Simvastatin—atherosclerosis	0.000766	0.00166	CcSEcCtD
Gemcitabine—Diarrhoea—Simvastatin—atherosclerosis	0.00074	0.00161	CcSEcCtD
Gemcitabine—Vomiting—Lovastatin—atherosclerosis	0.000736	0.0016	CcSEcCtD
Gemcitabine—Rash—Lovastatin—atherosclerosis	0.000729	0.00158	CcSEcCtD
Gemcitabine—Dermatitis—Lovastatin—atherosclerosis	0.000729	0.00158	CcSEcCtD
Gemcitabine—Headache—Lovastatin—atherosclerosis	0.000725	0.00157	CcSEcCtD
Gemcitabine—Vomiting—Ezetimibe—atherosclerosis	0.000721	0.00157	CcSEcCtD
Gemcitabine—Rash—Ezetimibe—atherosclerosis	0.000715	0.00155	CcSEcCtD
Gemcitabine—Dermatitis—Ezetimibe—atherosclerosis	0.000715	0.00155	CcSEcCtD
Gemcitabine—Asthenia—Niacin—atherosclerosis	0.000713	0.00155	CcSEcCtD
Gemcitabine—ABCB1—cardiovascular system—atherosclerosis	0.000711	0.00577	CbGeAlD
Gemcitabine—Headache—Ezetimibe—atherosclerosis	0.000711	0.00154	CcSEcCtD
Gemcitabine—Pruritus—Niacin—atherosclerosis	0.000703	0.00153	CcSEcCtD
Gemcitabine—Asthenia—Pravastatin—atherosclerosis	0.000702	0.00152	CcSEcCtD
Gemcitabine—Pruritus—Pravastatin—atherosclerosis	0.000692	0.0015	CcSEcCtD
Gemcitabine—Vomiting—Simvastatin—atherosclerosis	0.000688	0.00149	CcSEcCtD
Gemcitabine—Nausea—Lovastatin—atherosclerosis	0.000687	0.00149	CcSEcCtD
Gemcitabine—Rash—Simvastatin—atherosclerosis	0.000682	0.00148	CcSEcCtD
Gemcitabine—Dermatitis—Simvastatin—atherosclerosis	0.000682	0.00148	CcSEcCtD
Gemcitabine—Diarrhoea—Niacin—atherosclerosis	0.00068	0.00148	CcSEcCtD
Gemcitabine—Headache—Simvastatin—atherosclerosis	0.000678	0.00147	CcSEcCtD
Gemcitabine—Nausea—Ezetimibe—atherosclerosis	0.000674	0.00146	CcSEcCtD
Gemcitabine—Diarrhoea—Pravastatin—atherosclerosis	0.000669	0.00145	CcSEcCtD
Gemcitabine—Nausea—Simvastatin—atherosclerosis	0.000643	0.0014	CcSEcCtD
Gemcitabine—Vomiting—Niacin—atherosclerosis	0.000632	0.00137	CcSEcCtD
Gemcitabine—ABCB1—adipose tissue—atherosclerosis	0.000627	0.00509	CbGeAlD
Gemcitabine—Rash—Niacin—atherosclerosis	0.000626	0.00136	CcSEcCtD
Gemcitabine—Dermatitis—Niacin—atherosclerosis	0.000626	0.00136	CcSEcCtD
Gemcitabine—Headache—Niacin—atherosclerosis	0.000622	0.00135	CcSEcCtD
Gemcitabine—Vomiting—Pravastatin—atherosclerosis	0.000622	0.00135	CcSEcCtD
Gemcitabine—Rash—Pravastatin—atherosclerosis	0.000617	0.00134	CcSEcCtD
Gemcitabine—Dermatitis—Pravastatin—atherosclerosis	0.000616	0.00134	CcSEcCtD
Gemcitabine—Headache—Pravastatin—atherosclerosis	0.000613	0.00133	CcSEcCtD
Gemcitabine—Nausea—Niacin—atherosclerosis	0.00059	0.00128	CcSEcCtD
Gemcitabine—Nausea—Pravastatin—atherosclerosis	0.000581	0.00126	CcSEcCtD
Gemcitabine—ABCB1—liver—atherosclerosis	0.00044	0.00357	CbGeAlD
Gemcitabine—POLD1—Metabolism—CETP—atherosclerosis	0.000132	0.000683	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GPX1—atherosclerosis	0.000132	0.00068	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000131	0.000677	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000131	0.000674	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ABCA1—atherosclerosis	0.00013	0.000673	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—NAMPT—atherosclerosis	0.00013	0.00067	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—LIPC—atherosclerosis	0.000129	0.000666	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.000129	0.000664	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CD36—atherosclerosis	0.000128	0.000662	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—APOC3—atherosclerosis	0.000128	0.000662	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—SCARB1—atherosclerosis	0.000128	0.000659	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—LDLR—atherosclerosis	0.000127	0.000658	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.000127	0.000656	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SCARB1—atherosclerosis	0.000127	0.000655	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP27A1—atherosclerosis	0.000126	0.00065	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTGS2—atherosclerosis	0.000125	0.000648	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000125	0.000647	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CETP—atherosclerosis	0.000124	0.000643	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.000123	0.000636	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—MTHFR—atherosclerosis	0.000122	0.000627	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000121	0.000624	CbGpPWpGaD
Gemcitabine—POLE—Mitotic M-M/G1 phases—MAPK3—atherosclerosis	0.00012	0.000622	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—HMGCR—atherosclerosis	0.00012	0.000622	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.00012	0.00062	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—HMGCR—atherosclerosis	0.00012	0.000618	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALOX5AP—atherosclerosis	0.000119	0.000616	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PLA2G2A—atherosclerosis	0.000119	0.000616	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—APOA2—atherosclerosis	0.000119	0.000616	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALOX15—atherosclerosis	0.000119	0.000616	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PPARA—atherosclerosis	0.000119	0.000616	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—SCARB1—atherosclerosis	0.000119	0.000615	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ABCG5—atherosclerosis	0.000118	0.000609	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AGT—atherosclerosis	0.000115	0.000596	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.000115	0.000594	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—LPA—atherosclerosis	0.000114	0.000588	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—APOE—atherosclerosis	0.000113	0.000584	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—HMGCR—atherosclerosis	0.000113	0.000581	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CAV1—atherosclerosis	0.000112	0.000579	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—HMOX1—atherosclerosis	0.000112	0.000577	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—APOA1—atherosclerosis	0.000112	0.000577	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IFNG—atherosclerosis	0.000111	0.000574	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—BGN—atherosclerosis	0.00011	0.000569	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—APOA5—atherosclerosis	0.000109	0.000564	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ABCA1—atherosclerosis	0.000107	0.000554	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—APOB—atherosclerosis	0.000107	0.000553	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ABCA1—atherosclerosis	0.000107	0.000551	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PLA2G1B—atherosclerosis	0.000105	0.000543	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTM1—atherosclerosis	0.000104	0.000538	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	0.000103	0.000534	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—LPL—atherosclerosis	0.000102	0.000528	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CG—atherosclerosis	0.000102	0.000527	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALOX5—atherosclerosis	0.000101	0.000524	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ABCA1—atherosclerosis	0.0001	0.000518	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GPX1—atherosclerosis	9.98e-05	0.000515	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL1B—atherosclerosis	9.92e-05	0.000512	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	9.9e-05	0.000511	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PPARG—atherosclerosis	9.85e-05	0.000509	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	9.73e-05	0.000503	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CD36—atherosclerosis	9.72e-05	0.000502	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	9.69e-05	0.000501	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—INS—atherosclerosis	9.66e-05	0.000499	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MAPK3—atherosclerosis	9.38e-05	0.000485	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MAPK3—atherosclerosis	9.33e-05	0.000482	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—HMOX1—atherosclerosis	9.21e-05	0.000476	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—MTHFR—atherosclerosis	9.21e-05	0.000476	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—HMOX1—atherosclerosis	9.15e-05	0.000473	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NAMPT—atherosclerosis	9.1e-05	0.00047	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—LIPC—atherosclerosis	9.04e-05	0.000467	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PPARA—atherosclerosis	9.03e-05	0.000467	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MAPK3—atherosclerosis	9.01e-05	0.000465	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—APOC3—atherosclerosis	8.99e-05	0.000464	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	8.97e-05	0.000463	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	8.94e-05	0.000462	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—LDLR—atherosclerosis	8.93e-05	0.000461	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—IL6—atherosclerosis	8.91e-05	0.00046	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ALB—atherosclerosis	8.86e-05	0.000458	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—APOB—atherosclerosis	8.82e-05	0.000456	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—APOB—atherosclerosis	8.77e-05	0.000453	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AGT—atherosclerosis	8.75e-05	0.000452	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CETP—atherosclerosis	8.73e-05	0.000451	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	8.67e-05	0.000448	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—HMOX1—atherosclerosis	8.61e-05	0.000444	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—MAPK3—atherosclerosis	8.58e-05	0.000443	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTM1—atherosclerosis	8.58e-05	0.000443	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—APOE—atherosclerosis	8.57e-05	0.000443	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	8.57e-05	0.000442	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTM1—atherosclerosis	8.53e-05	0.00044	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CAV1—atherosclerosis	8.49e-05	0.000439	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—APOA1—atherosclerosis	8.48e-05	0.000438	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—NOS3—atherosclerosis	8.48e-05	0.000438	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—LPL—atherosclerosis	8.42e-05	0.000435	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	8.4e-05	0.000434	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MAPK3—atherosclerosis	8.39e-05	0.000433	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—LPL—atherosclerosis	8.37e-05	0.000432	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SCARB1—atherosclerosis	8.36e-05	0.000432	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MAPK3—atherosclerosis	8.34e-05	0.000431	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—APOB—atherosclerosis	8.24e-05	0.000426	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GPX1—atherosclerosis	8.22e-05	0.000424	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GPX1—atherosclerosis	8.17e-05	0.000422	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	8.07e-05	0.000417	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MAPK3—atherosclerosis	8.05e-05	0.000416	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTM1—atherosclerosis	8.02e-05	0.000414	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CD36—atherosclerosis	8e-05	0.000413	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CD36—atherosclerosis	7.95e-05	0.000411	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—HMGCR—atherosclerosis	7.89e-05	0.000408	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—LPL—atherosclerosis	7.87e-05	0.000406	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	7.77e-05	0.000401	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—atherosclerosis	7.75e-05	0.0004	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CG—atherosclerosis	7.74e-05	0.0004	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	7.71e-05	0.000398	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GPX1—atherosclerosis	7.68e-05	0.000397	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—MTHFR—atherosclerosis	7.58e-05	0.000392	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—MTHFR—atherosclerosis	7.54e-05	0.000389	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CD36—atherosclerosis	7.48e-05	0.000386	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PPARG—atherosclerosis	7.47e-05	0.000386	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPARA—atherosclerosis	7.44e-05	0.000384	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPARA—atherosclerosis	7.39e-05	0.000382	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	7.33e-05	0.000378	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—INS—atherosclerosis	7.32e-05	0.000378	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AGT—atherosclerosis	7.21e-05	0.000372	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TNF—atherosclerosis	7.2e-05	0.000372	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—LDLRAP1—atherosclerosis	7.19e-05	0.000371	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AGT—atherosclerosis	7.16e-05	0.00037	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—MTHFR—atherosclerosis	7.09e-05	0.000366	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—APOE—atherosclerosis	7.06e-05	0.000365	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ABCA1—atherosclerosis	7.03e-05	0.000363	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—APOE—atherosclerosis	7.02e-05	0.000362	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CAV1—atherosclerosis	7e-05	0.000361	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—APOA1—atherosclerosis	6.98e-05	0.00036	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CAV1—atherosclerosis	6.95e-05	0.000359	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPARA—atherosclerosis	6.95e-05	0.000359	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—APOA1—atherosclerosis	6.94e-05	0.000358	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PLTP—atherosclerosis	6.76e-05	0.000349	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AGT—atherosclerosis	6.73e-05	0.000348	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ALB—atherosclerosis	6.71e-05	0.000347	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—APOE—atherosclerosis	6.6e-05	0.000341	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CAV1—atherosclerosis	6.54e-05	0.000338	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—APOA1—atherosclerosis	6.52e-05	0.000337	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—NOS3—atherosclerosis	6.42e-05	0.000332	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MAPK3—atherosclerosis	6.42e-05	0.000331	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CG—atherosclerosis	6.37e-05	0.000329	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	6.34e-05	0.000328	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CG—atherosclerosis	6.33e-05	0.000327	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—AKT1—atherosclerosis	6.31e-05	0.000326	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	6.19e-05	0.000319	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPARG—atherosclerosis	6.15e-05	0.000318	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MAPK3—atherosclerosis	6.15e-05	0.000318	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPARG—atherosclerosis	6.11e-05	0.000316	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—HMOX1—atherosclerosis	6.03e-05	0.000312	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—INS—atherosclerosis	6.03e-05	0.000311	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—INS—atherosclerosis	5.99e-05	0.00031	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CG—atherosclerosis	5.95e-05	0.000307	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—atherosclerosis	5.87e-05	0.000303	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—LTA4H—atherosclerosis	5.86e-05	0.000303	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ABCG8—atherosclerosis	5.86e-05	0.000303	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—APOB—atherosclerosis	5.78e-05	0.000298	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	5.75e-05	0.000297	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPARG—atherosclerosis	5.75e-05	0.000297	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MAPK3—atherosclerosis	5.74e-05	0.000296	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—INS—atherosclerosis	5.64e-05	0.000291	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTM1—atherosclerosis	5.62e-05	0.00029	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ALB—atherosclerosis	5.53e-05	0.000286	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—LPL—atherosclerosis	5.52e-05	0.000285	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MAPK3—atherosclerosis	5.5e-05	0.000284	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ALB—atherosclerosis	5.5e-05	0.000284	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GPX1—atherosclerosis	5.38e-05	0.000278	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—NOS3—atherosclerosis	5.29e-05	0.000273	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	5.26e-05	0.000272	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NOS3—atherosclerosis	5.26e-05	0.000271	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CD36—atherosclerosis	5.24e-05	0.000271	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ALB—atherosclerosis	5.17e-05	0.000267	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	5.07e-05	0.000262	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—MTHFR—atherosclerosis	4.97e-05	0.000257	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—NOS3—atherosclerosis	4.94e-05	0.000255	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARA—atherosclerosis	4.88e-05	0.000252	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—atherosclerosis	4.84e-05	0.00025	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—atherosclerosis	4.81e-05	0.000248	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AGT—atherosclerosis	4.72e-05	0.000244	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ABCG1—atherosclerosis	4.64e-05	0.000239	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—APOE—atherosclerosis	4.63e-05	0.000239	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CAV1—atherosclerosis	4.58e-05	0.000237	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—APOA1—atherosclerosis	4.57e-05	0.000236	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	4.56e-05	0.000236	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—atherosclerosis	4.52e-05	0.000233	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	4.49e-05	0.000232	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—FABP4—atherosclerosis	4.36e-05	0.000225	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—LCAT—atherosclerosis	4.36e-05	0.000225	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	4.31e-05	0.000222	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APOA4—atherosclerosis	4.28e-05	0.000221	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP7A1—atherosclerosis	4.2e-05	0.000217	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CG—atherosclerosis	4.18e-05	0.000216	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	4.14e-05	0.000214	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARG—atherosclerosis	4.03e-05	0.000208	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.98e-05	0.000205	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—INS—atherosclerosis	3.95e-05	0.000204	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	3.92e-05	0.000202	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AKT1—atherosclerosis	3.9e-05	0.000201	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP27A1—atherosclerosis	3.88e-05	0.000201	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	3.81e-05	0.000197	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	3.8e-05	0.000196	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALOX5AP—atherosclerosis	3.68e-05	0.00019	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALOX15—atherosclerosis	3.68e-05	0.00019	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APOA2—atherosclerosis	3.68e-05	0.00019	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PLA2G2A—atherosclerosis	3.68e-05	0.00019	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ABCG5—atherosclerosis	3.64e-05	0.000188	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALB—atherosclerosis	3.62e-05	0.000187	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	3.55e-05	0.000183	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—LPA—atherosclerosis	3.51e-05	0.000181	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NOS3—atherosclerosis	3.47e-05	0.000179	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—BGN—atherosclerosis	3.4e-05	0.000176	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APOA5—atherosclerosis	3.37e-05	0.000174	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	3.24e-05	0.000167	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.21e-05	0.000166	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—atherosclerosis	3.17e-05	0.000164	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALOX5—atherosclerosis	3.13e-05	0.000162	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.01e-05	0.000156	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKT1—atherosclerosis	2.95e-05	0.000152	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NAMPT—atherosclerosis	2.81e-05	0.000145	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—LIPC—atherosclerosis	2.79e-05	0.000144	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APOC3—atherosclerosis	2.77e-05	0.000143	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—LDLR—atherosclerosis	2.76e-05	0.000142	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CETP—atherosclerosis	2.69e-05	0.000139	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.64e-05	0.000137	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SCARB1—atherosclerosis	2.58e-05	0.000133	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HMGCR—atherosclerosis	2.43e-05	0.000126	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKT1—atherosclerosis	2.43e-05	0.000126	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKT1—atherosclerosis	2.42e-05	0.000125	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.39e-05	0.000123	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKT1—atherosclerosis	2.27e-05	0.000117	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ABCA1—atherosclerosis	2.17e-05	0.000112	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HMOX1—atherosclerosis	1.86e-05	9.62e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APOB—atherosclerosis	1.78e-05	9.21e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTM1—atherosclerosis	1.73e-05	8.96e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—LPL—atherosclerosis	1.7e-05	8.79e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GPX1—atherosclerosis	1.66e-05	8.58e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CD36—atherosclerosis	1.62e-05	8.36e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKT1—atherosclerosis	1.59e-05	8.23e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MTHFR—atherosclerosis	1.53e-05	7.92e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARA—atherosclerosis	1.5e-05	7.77e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AGT—atherosclerosis	1.46e-05	7.52e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APOE—atherosclerosis	1.43e-05	7.37e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CAV1—atherosclerosis	1.41e-05	7.3e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APOA1—atherosclerosis	1.41e-05	7.29e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.29e-05	6.65e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARG—atherosclerosis	1.24e-05	6.42e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—INS—atherosclerosis	1.22e-05	6.3e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALB—atherosclerosis	1.12e-05	5.77e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NOS3—atherosclerosis	1.07e-05	5.52e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—atherosclerosis	9.78e-06	5.05e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKT1—atherosclerosis	4.92e-06	2.54e-05	CbGpPWpGaD
